Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1696250

Cover Image

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1696250

Global Omega-3 Market - 2025-2032

PUBLISHED:
PAGES: 180 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4350
PDF & Excel (Multiple User License)
USD 4850
PDF & Excel (Enterprise License)
USD 7850

Add to Cart

Global Omega-3 Market reached US$ 2.64 billion in 2024 and is expected to reach US$ 4.85 billion by 2032, growing with a CAGR of 7.92% during the forecast period 2025-2032.

The market expansion is due to the increasing use of omega-3 ingredients in the human diet to enhance brain and heart health. Furthermore, rising consumer spending in healthcare and personal well-being is predicted to drive product demand. The market is constantly diversifying its product sources as consumers seek alternatives to traditional fish oil. Krill oil is one of the most extensively used sources of omega-3 because of its superior qualities when compared to regular fish oil.

Furthermore, significant enterprises like as Aker Biomarine Antarctic AS are working on boosting capacity by introducing new catching vessels to increase their product offerings, as evidenced by the company's revenues in 2021. Governments in developing countries are launching a number of initiatives to encourage Antarctic Krill fishing, including providing research money and forming innovative alliances, which could spur industry growth. Such variables are expected to drive the product demand during the forecast period.

Dynamic

Rising Health Benefits of Omega-3

Omega-3s, notably EPA and DHA, are required in the human diet for appropriate growth, development and health. They are beneficial for heart health, joint and inflammation relief, eye health, cognitive function, pregnancy and child development and immune function. Omega-3 fatty acids are recognized to lessen the risk of cardiovascular disease. Cardiovascular disease mortality has recently been on the rise around the world. In Western Sub-Saharan Africa and South Asia, cardiovascular disease rates have risen. According to the United Nations Population Fund (India), the number of instances of heart disease among older adults in India is anticipated to be 19.1 million by 2050.

Countries such as India and China, where the prevalence of heart disease is expanding, create demand for heart health goods, bolstering the omega-3 product market. Omega-3 fatty acids can also help prevent and treat several eye problems, including dry eye syndrome. According to studies, ingesting omega-3 fatty acids, whether in meals or supplements, may lower your chance of getting macular degeneration and glaucoma. As a result, omega-3's benefits in different aspects of human health are projected to boost its market demand.

Supply Chain Constraints and Sustainability Challenges

One of the primary constraints in the global omega-3 market is the scarcity of fish oil-based raw materials due to overfishing issues and environmental regulations. The majority of omega-3 production comes from marine sources including anchovies, sardines and mackerel, which are subject to seasonal changes, geopolitical constraints and sustainability demands.

For example, in 2023, Peru, the world's top producer of anchovy-based fish oil, implemented fishing prohibitions owing to diminishing fish populations, resulting in supply shortages and price instability in the omega-3 market. As a result, manufacturers are now searching for alternate sources like algae-derived omega-3, although these are still more expensive and require more scalability to satisfy expanding worldwide demand.

Segment Analysis

The global omega-3 market is segmented based on source, type, application and region.

DHA in the global market is expected to drive the market.

In 2024, the DHA segment accounted for the largest percentage of global omega-3 market. The segment's growth is due to the increasing use of the product in newborn formulae to improve an infant's overall health. DHA is the most vital and plentiful omega-3 fatty acid in the human diet, contributing to overall body health. DHA is essential for the development and maturation of an infant's brain and vision.

Furthermore, it is commonly utilized in dietary supplements and fortified foods. It is used to treat dementia, ADHD, CAD and type 2 diabetes. Companies create new items to fulfill market demand. For example, in 2022 orlo Nutrition launched a DHA Starter Kit with an algal omega-3 supplement to assist the brain, heart, joints and body systems.

Geographical Penetration

Growing Health Consciousness in Asia-Pacific.

Asia-Pacific is expected to be the fastest growing region in the global omega-3 market. Several reasons fueling the region's growth include expanding consumer health consciousness, an aging population valuing cognitive health and high birth rates, which increase demand for infant nutritional products. Additionally, the popularity of plant-based diets has resulted in an increase in demand for algae-based omega-3 supplements.

Furthermore, other significant players have innovated, such as Daewoong Bio, which developed CRA-TG in June 2024, a combination of the hyperlipidemia medicine rosuvastatin and omega-3 intended at lowering patients' triglyceride levels. This new addition to Daewoong Bio's hyperlipidemia treatment range joins nine other medications, including Atorvastatin Tablets and Oma-TG Soft Capsule. CRA-TG has exhibited better lipid profiles and increased tolerance and stability.

Competitive Landscape

The major global players in the market include Polaris, Koninklijke DSM N.V., BASF SE, Corbion NV, ADM, Simris Alg AB, Croda International Plc, Novotech Nutraceuticals, Inc., Source Omega LLC and Algarithm.

Key Developments

  • In January 2024, Ritual introduced the Omega-3 DHA + EPA supplement. It contains 500 mg of omega-3 fatty acids in a 2:1 ratio of DHA and EPA. The oil is sustainably sourced from microalgae in La Foret-Fouesnant, France and processed using unique technique to minimize oxidation, resulting in minimal burp-back.
  • In March 2023, Epax announced a $40 million investment in molecular distillation technology to enhance the processing of highly concentrated omega 3.
  • In May 2023, Nuseed Global will launch Nuseed Nutriterra, an omega-3-enriched plant-based oil designed for the human nutrition and dietary supplement industries.

Why Choose DataM?

  • Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
  • Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
  • White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
  • Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
  • Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than Source generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
  • Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.

Target Audience 2024

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies
Product Code: FB9407

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Source
  • 3.2. Snippet by Type
  • 3.3. Snippet by Application
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Health Benefits of Omega-3
    • 4.1.2. Restraints
      • 4.1.2.1. Supply Chain Constraints and Sustainability Challenges
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Sustainable Analysis
  • 5.6. DMI Opinion

6. By Source

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 6.1.2. Market Attractiveness Index, By Source
  • 6.2. Algae*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Fish
  • 6.4. Krill
  • 6.5. Others

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. Docosahexaenoic Acid (DHA)*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Eicosapentaenoic Acid (EPA)
  • 7.4. Alpha-Linolenic Acid (ALA)
  • 7.5. Others

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Functional Foods and Beverage*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 8.2.3. Vegetable Oil
    • 8.2.4. Shea Butter
  • 8.3. Dietary Supplements
  • 8.4. Infant Formula
  • 8.5. Cosmetics
  • 8.6. Animal Nutrition
  • 8.7. Others

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. U.S.
      • 9.2.6.2. Canada
      • 9.2.6.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. UK
      • 9.3.6.3. France
      • 9.3.6.4. Italy
      • 9.3.6.5. Spain
      • 9.3.6.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Brazil
      • 9.4.6.2. Argentina
      • 9.4.6.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. Australia
      • 9.5.6.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. Polaris*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
  • 11.2. Koninklijke DSM N.V.
  • 11.3. BASF SE
  • 11.4. Corbion NV
  • 11.5. ADM
  • 11.6. Simris Alg AB
  • 11.7. Croda International Plc
  • 11.8. Novotech Nutraceuticals, Inc.
  • 11.9. Source Omega LLC
  • 11.10. Algarithm

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!